Condition
Immune Modulation
A mechanism studied across diseases, not an indication.
Quick summary
- • Primarily preclinical
Overview
Immune modulation is frequently cited in cell research.
Mechanisms studied
T-cell responses and macrophage polarisation are studied.
Human research
No clinical conclusions yet.
Safety
Reported adverse events are mostly local — swelling, pain, or bruising at the harvest and injection sites. Infection and cell-processing quality remain the key risks to monitor.
Evidence limitations
Existing studies are limited by sample size, methodology, and follow-up, and SVF preparation differs substantially between centres, making cross-study comparison difficult.
Related research
- InsufficientClinical Trial
Efficacy and safety of autologous adipose tissue-derived stromal vascular fraction in patients with premature ovarian insufficiency: protocol for a single-centre randomised controlled trial
A pre-published randomized trial protocol testing SVF in premature ovarian insufficiency — no results yet.
- 2025
- China
- InsufficientLaboratory Study
Understanding and controlling the variables for stromal vascular fraction therapy
Review tracing the variables from liposuction technique and donor site through enzymatic digestion, filtration, centrifugation and cell viability testing.
- 2024
- India
Last updated: 2026-06-18 · arisa-w